A Study on Aluminium Levels in Patients Undergoing Haemodialysis at a Tertiary Care Hospital

Published on:September 2020
Indian Journal of Pharmacy Practice, 2020; 13(3):252-258
Research Article | doi:10.5530/ijopp.13.3.41

A Study on Aluminium Levels in Patients Undergoing Haemodialysis at a Tertiary Care Hospital

Authors and affiliation (s):

Hafeez Abdul Kader2,3, Neelathahalli Kasturirangan Meera3, Abubakar Siddique1,3,*, Ashfaque Ahmed2,3

1Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, SAUDI ARABIA.

2United Doctors Hospitals, Jeddah, SAUDI ARABIA.

3Department of Pharmacy Practice, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru-560070, Karnataka, INDIA.


Introduction: Aluminium studied as a potentially toxic metal and is commonly found in earth’s crust. Aluminium toxicity may lead to: aluminium-induced bone disease, microcytic anaemia and neurological manifestation, such conditions more particular seen in patients with chronic renal failure and principally patients on haemodialysis. Objectives: The objective of our study was to measure a serum aluminium levels in patients undergoing haemodialysis at tertiary care hospital, Bengaluru. Materials and Methods: This was a prospective study, conducted on 50 patients who were on maintenance haemodialysis for more than 6 months. 5 ml of the blood was drawn from the antecubital vein from the patient before haemodialysis process. Collected blood samples were estimated for aluminium levels by GFAAS. The dialysis fluid and RO water were also tested similarly for presence of aluminium to correlate the possible contamination. Results: The results were; 6(12%) patients had serum aluminium levels within baseline i.e. <20μg/L, 18(36%) patients had serum aluminium levels between 21-60μg/L and 26 (52%) of the patients had serum aluminium levels above 60μg/L. The aluminium content varied in the dialysate fluid reaching greater than the standard safety limit. Conclusion: In our study we found that aluminium toxicity is a serious problem in patients undergoing haemodialysis. Patients performing haemodialysis for longer period showed higher level of aluminium. Patients age of 50 years and on haemodialysis for duration 3 years need to be monitored carefully for aluminium toxicity. The major source of elevated serum aluminium in our study participants appears to be dialysate fluid, use of aluminium utensils, OTC products and food habits of consult patients.

Key words: Aluminium toxicity, Haemodialysis, CRF, Nephrology, GFAAS.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs